Clinical trial condition

NASH

Explore clinical trials studying NASH. Study availability and eligibility vary by location and protocol.

42 public trials 11 recruiting studies

Refine in advanced search Browse all conditions

NASH trial results

Completed

The Visceral Adiposity Measurement and Observation Study

NCT05383456

Conditions: Acquired Immunodeficiency Syndrome, BMI, Blood-Borne Infections, +47 more
Locations: Ruane Clinical Research Los Angeles, California, United States

AIDS Healthcare Foundation Fort Lauderdale, Florida, United States

AIDS Healthcare Foundation Miami Beach, Florida, United States

AIDS Healthcare Foundation Miami Beach, Florida, United States

View Trial Details

Completed

Effects of Online App Weight Loss Programs on Liver Health in Obese Adults

NCT05015491

Conditions: Body Weight, Body Weight Changes, Digestive System Diseases, +8 more
Locations: Arizona Liver Health Chandler, Arizona, United States

View Trial Details

Completed

An Open-Label, Two-Part Study Designed to Assess the Absolute Bioavailability and Mass Balance of Aramchol

NCT05874336

Conditions: NASH
Locations: Quotient Sciences, Mere Way, Ruddington Fields, Ruddington, Nottingham, NG11 6JS, UK. Nottingham, United Kingdom

View Trial Details

Completed

Misoprostol for NASH

NCT05804305

Conditions: NASH
Locations: Dr. Ziauddin Hospital Clifton Karachi, Sindh, Pakistan

View Trial Details

Completed

Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)

NCT02923154

Conditions: NASH
Locations: Investigational site Kanagawa, Japan

Investigational site Osaka, Japan

View Trial Details

Completed

A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

NCT03207425

Conditions: NASH
Locations: American Research Corporation at The Texas Liver Institute San Antonio, Texas, United States

Pharmaceuticals Research Associates Prague, Czechia

Summit SRO Bratislava, Slovakia

View Trial Details

Completed

Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers.

NCT03187496

Conditions: NASH
Locations: Pharmaceutical Research Associates, Inc., Lenexa, Kansas, United States

View Trial Details

Active, Not Recruiting

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

NCT05500222

Conditions: Cirrhosis, Liver, Digestive System Diseases, Fibrosis, +5 more
Locations: University of Alabama at Birmingham (UAB) Birmingham, Alabama, United States

Arizona Liver Health - Chandler Chandler, Arizona, United States

Arizona Liver Health - Peoria Peoria, Arizona, United States

Adobe Clinical Research Tucson, Arizona, United States

View all 141 locations

View Trial Details

Active, Not Recruiting

A Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of VSA006 in Chinese NASH Patients

NCT06322628

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Beijing Tsinghua Changgeng Hospital Beijing, Beijing Municipality, China

View Trial Details

Active, Not Recruiting

An Imaging-based Quantitative Biomarker Assay for NAFLD in Children

NCT06354491

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +3 more
Locations: University of Wisconsin, Madison Madison, Wisconsin, United States

View Trial Details

NASH

NASH trial results

Related conditions